klercide sporicidal active chlorine unit dose concentrate
ecolab deutschland gmbh -
yselty
theramex ireland limited - linzagolix choline - uterusa - hipofiza i hipotalamusni hormoni i analozi - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
luxturna
novartis europharm limited - voretigene neparvovec - leber congenital amaurosis; retinitis pigmentosa - other ophthalmologicals - luxturna je indiciran za liječenje i odjelu odraslih bolesnika s gubitkom vida zbog ostavština distrofije mrežnice uzrokovana potvrdio rpe65 биаллельных mutacija i koji imaju dovoljno živih stanica mrežnice.
hiramicin 100 mg tvrde kapsule
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - doxycyclinum - kapsula, tvrda - 100 mg - urbroj: 1 kapsula sadrži 100 mg doksiciklina u obliku doksiciklinhiklata
ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektivni imunosupresivi - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
doksiciklin belupo 100 mg tvrde kapsule
belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - doksiciklinhiklat - kapsula, tvrda - 100 mg - urbroj: jedna kapsula sadrži 100 mg doksiciklina u obliku doksiciklinhiklata
hiramicin 100 mg/1 kapsula kapsula, tvrda
pliva d.o.o.sarajevo - doksiciklin - kapsula, tvrda - 100 mg/1 kapsula - 1 tvrda kapsula sadrži: 100 mg doksiciklina (u obliku doksiciklinhiklata)